
zzso pharmacological zzso zzso zzso prophylaxis beyond discharge is recommended for patients undergoing high-risk zzso We zzso investigated prophylaxis in zzso consecutive patients undergoing major zzso zzso or major cancer surgery zzso in 14 Swiss zzso zzso zzso prophylaxis was used in zzso zzso zzso At zzso zzso zzso patients received prescription for extended pharmacological zzso zzso zzso after zzso surgery, and 74 zzso after cancer surgery zzso zzso zzso Patients with knee replacement zzso hip replacement zzso major trauma zzso and zzso zzso zzso had the highest prescription rates for extended zzso zzso the lowest rates were found in patients undergoing major surgery for zzso zzso gastrointestinal zzso and zzso zzso zzso The median duration of prescribed extended prophylaxis was longer in patients with zzso surgery (32 days, zzso range zzso zzso than in patients with cancer surgery zzso days, zzso range zzso zzso zzso Among the zzso patients with an extended prophylaxis order after hip replacement, knee replacement, or hip fracture surgery, 120 zzso received a prescription for at least 35 days, and among the 74 patients with an extended prophylaxis order after major cancer surgery, 20 zzso received a prescription for at least 28 zzso In conclusion, approximately one quarter of the patients with major zzso surgery and more than three quarters of the patients with major cancer surgery did not receive prescription for extended zzso zzso Future effort should focus on the improvement of extended zzso zzso particularly in patients undergoing major cancer zzso 

